LEXEO THERAPEUTICS

lexeo-therapeutics-logo

LEXEO Therapeutics is a fully integrated biotechnology company. LEXEO Therapeuticsโ€™ pipeline consists of adeno-associated virus (AAV)-mediated therapies primarily developed at Weill Cornell Medicineโ€™s Department of Genetic Medicine. Beyond LEXEO Therapeuticsโ€™ lead programs โ€“ which are focused on both rare and non-rare monogenic (single genemutation) diseases โ€“ the companyโ€™s preclinical pipeline spans monogenic diseases, as well as hereditary and acquired diseases across a spectrum o... f patient population sizes and a range of unmet medical needs. Importantly, LEXEO Therapeutics will focus on advancing clinical programs through to commercialization, with the goal of maintaining an ongoing research collaboration with Weill Cornell Medicineโ€™s Department of Genetic Medicine to help advance the companyโ€™s pre-clinical pipeline.

#SimilarOrganizations #People #Financial #Website #More

LEXEO THERAPEUTICS

Social Links:

Industry:
Biotechnology Life Science Therapeutics

Founded:
2018-01-01

Address:
New York, New York, United States

Country:
United States

Website Url:
http://www.lexeotx.com

Total Employee:
11+

Status:
Active

Contact:
(212) 547-9879

Email Addresses:
[email protected]

Total Funding:
185 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Google Tag Manager WordPress Google Universal Analytics Apache


Similar Organizations

accent-therapeutics-logo

Accent Therapeutics

Accent Therapeutics is a biopharmaceutical company.

asgard-therapeutics-logo

Asgard Therapeutics

Asgard Therapeutics is a Biotechnology Company.

curasen-therapeutics-logo

CuraSen Therapeutics

CuraSen Therapeutics is a biopharmaceutical company.

cygnal-therapeutics-logo

Cygnal Therapeutics

Cygnal Therapeutics is a biotechnology company

emendo-biotherapeutics-logo

Emendo Biotherapeutics

Emendo Biotherapeutics is a biotechnology company

excellthera-logo

ExCellThera

ExCellThera is an advanced clinical stage biotechnology company.

faze-medicines-logo

Faze Medicines

Faze Medicines is a biotechnology company.

immunicom-logo

Immunicom

Immunicom is a biotechnology company.

libra-therapeutics-logo

Libra Therapeutics

Libra Therapeutics is a biotechnology company.

moma-therapeutics-logo

MOMA Therapeutics

MOMA Therapeutics operates as a biotechnology company.

primmune-therapeutics-logo

Primmune Therapeutics

Primmune Therapeutics is a Biotechnology company.

not_available_image

Rekindle Therapeutics

Rekindle Therapeutics is a biotechnology company.

terray-therapeutics-logo

Terray Therapeutics

Terray Therapeutics is a biotechnology company.

werewolf-therapeutics-logo

Werewolf Therapeutics

Werewolf Therapeutics operates as an oncology biotherapeutics company.

xios-therapeutics-logo

Xios Therapeutics

Xios Therapeutics is a biotechnology company .


Current Advisors List

sandip-agarwala_image

Sandip Agarwala Board Member @ LEXEO Therapeutics
Board_member
2020-11-07

mette-kirstine-agger_image

Mette Kirstine Agger Board Member @ LEXEO Therapeutics
Board_member
2021-01-07

bernard-davitian_image

Bernard Davitian Board Member @ LEXEO Therapeutics
Board_member
2021-01-07

Current Employees Featured

ronald-g-crystal_image

Ronald G. Crystal
Ronald G. Crystal Founder, Chief Scientific Advisor & Board Observer @ LEXEO Therapeutics
Founder, Chief Scientific Advisor & Board Observer

r-nolan-townsend_image

R. Nolan Townsend
R. Nolan Townsend CEO @ LEXEO Therapeutics
CEO
2020-01-01

Founder


ronald-g-crystal_image

Ronald G. Crystal

Acquisitions List

Date Company Article Price
2021-07-21 Stelios Therapeutics Stelios Therapeutics acquired by LEXEO Therapeutics N/A

Investors List

janus-henderson-investors_image

Janus Henderson Investors

Janus Henderson Investors investment in Series B - LEXEO Therapeutics

gray-s-creek-capital-partners_image

Grayโ€™s Creek Capital Partners

Grayโ€™s Creek Capital Partners investment in Series B - LEXEO Therapeutics

omega-funds_image

Omega Funds

Omega Funds investment in Series B - LEXEO Therapeutics

eventide-asset-management_image

Eventide

Eventide investment in Series B - LEXEO Therapeutics

verition-fund-management_image

Verition Fund Management

Verition Fund Management investment in Series B - LEXEO Therapeutics

laurion-capital-management_image

Laurion Capital Management

Laurion Capital Management investment in Series B - LEXEO Therapeutics

intus-capital_image

Intus Capital

Intus Capital investment in Series B - LEXEO Therapeutics

alexandria-venture-investments_image

Alexandria Venture Investments

Alexandria Venture Investments investment in Series B - LEXEO Therapeutics

camcapital_image

CAM Capital

CAM Capital investment in Series B - LEXEO Therapeutics

d1-capital-partners_image

D1 Capital Partners

D1 Capital Partners investment in Series B - LEXEO Therapeutics

Official Site Inspections

http://www.lexeotx.com Semrush global rank: 528.08 K Semrush visits lastest month: 91.71 K

  • Host name: vps34638.dreamhostps.com
  • IP address: 67.205.19.65
  • Location: Brea United States
  • Latitude: 33.9339
  • Longitude: -117.8854
  • Metro Code: 803
  • Timezone: America/Los_Angeles
  • Postal: 92821

Loading ...

More informations about "LEXEO Therapeutics" on Search Engine